Early Lymphedema Risk Assessment: Expert Insights from Dr. Sheri Prentiss

A “wait and see” approach doesn’t work for lymphedema.

In this interview with CURE®, Sheri Yolanda Prentiss MD MPH CPS/A CPE FACPE CSP® Prentiss shares how her own experience with breast cancer-related lymphedema reshaped her view of survivorship care — and why early risk assessment matters.

Symptoms can take months or even years to appear. By the time they’re visible, the impact on quality of life, function, and long-term management can already be significant.

Shifting toward earlier assessment and shared decision-making isn’t just a clinical change — it changes the trajectory of survivorship.

Read the full article: https://www.impedimed.com/expert-dr-sheri-prentiss-discusses-early-lymphedema-risk-assessment/
#CancerSurvivorship #BreastCancerCare #MedTech #DigitalHealth